Kevin Cook, Sterling Pharma Solutions CEO

British CD­MO Ster­ling part­ners up on low-cost man­u­fac­tur­ing of mol­nupi­ravir

A British CD­MO and the Uni­ver­si­ty of Man­ches­ter have teamed up to sup­port the de­vel­op­ment of low-cost man­u­fac­tur­ing of mol­nupi­ravir, the an­tivi­ral pill for Covid …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.